These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 3566720)

  • 1. Liposome-bound cortisol: a new approach to cutaneous therapy.
    Lasch J; Wohlrab W
    Biomed Biochim Acta; 1986; 45(10):1295-9. PubMed ID: 3566720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration kinetics of liposomal hydrocortisone in human skin.
    Wohlrab W; Lasch J
    Dermatologica; 1987; 174(1):18-22. PubMed ID: 3803670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Skin permeation of liposomal incorporated hydrocortisone].
    Wohlrab W; Lasch J; Taube KM; Wozniak KD
    Pharmazie; 1989 May; 44(5):333-5. PubMed ID: 2772013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of liposomal incorporation of topically applied hydrocortisone on its serum concentration and urinary excretion.
    Wohlrab W; Lasch J
    Dermatol Monatsschr; 1989; 175(6):348-52. PubMed ID: 2759315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
    Padamwar MN; Pokharkar VB
    Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
    Bhatia A; Kumar R; Katare OP
    J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposome-incorporated corticosteroids: I. The interaction of liposomal cortisol palmitate with inflammatory synovial membrane.
    Shaw IH; Knight CG; Thomas DP; Phillips NC; Dingle JT
    Br J Exp Pathol; 1979 Apr; 60(2):142-50. PubMed ID: 444417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomes: a drug carrier system for topical treatment in dermatology.
    Schmid MH; Korting HC
    Crit Rev Ther Drug Carrier Syst; 1994; 11(2-3):97-118. PubMed ID: 7600589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conventional glucocorticoid replacement overtreats adult hypopituitary patients with partial ACTH deficiency.
    Agha A; Liew A; Finucane F; Baker L; O'Kelly P; Tormey W; Thompson CJ
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):688-93. PubMed ID: 15163331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery.
    Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
    Int J Pharm; 2006 Apr; 312(1-2):53-60. PubMed ID: 16469460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect on plasma cortisol level and urinary cortisol excretion, in healthy volunteers, after application of three different topical steroid ointments under occlusion.
    Scott M; Malmsten LA; Thelin I
    Acta Derm Venereol; 1981; 61(6):543-6. PubMed ID: 6177167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
    Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
    Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducing effect of liposomalization on the transdermal delivery of hydrocortisone: creation of a drug supersaturated state.
    Barichello JM; Handa H; Kisyuku M; Shibata T; Ishida T; Kiwada H
    J Control Release; 2006 Sep; 115(1):94-102. PubMed ID: 16919352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomes in topical drug delivery.
    Schaeffer HE; Krohn DL
    Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):220-7. PubMed ID: 7056633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relation between the prolongation of the anti-inflammatory activity of liposome-encapsulated hydrocortisone and liposome composition in experimental arthritis].
    Davidenkova EF; Ternova NK; Rozenberg OA; Noskin LA; Loshakova LV
    Biull Eksp Biol Med; 1984 Jun; 97(6):656-8. PubMed ID: 6743798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary delivery of insulin by liposomal carriers.
    Huang YY; Wang CH
    J Control Release; 2006 Jun; 113(1):9-14. PubMed ID: 16730838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cortisol in critically ill patients with sepsis: physiologic functions and therapeutic implications].
    Briegel J
    Wien Klin Wochenschr; 2000 Apr; 112(8):341-52. PubMed ID: 10849939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a new topical system: drug-in-cyclodextrin-in-deformable liposome.
    Gillet A; Grammenos A; Compère P; Evrard B; Piel G
    Int J Pharm; 2009 Oct; 380(1-2):174-80. PubMed ID: 19576972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes.
    Song YK; Kim CK
    Biomaterials; 2006 Jan; 27(2):271-80. PubMed ID: 16039711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index.
    Schäcke H; Berger M; Rehwinkel H; Asadullah K
    Mol Cell Endocrinol; 2007 Sep; 275(1-2):109-17. PubMed ID: 17630119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.